Digital Health Company to Use New Investment Funds to Grow Team and Expand Reach
CHICAGO–(BUSINESS WIRE)–#glucose—NutriSense, the metabolic health technology platform that couples real-time data with credentialed nutrition professionals for personalized support, announced the initial closing of a $25 million Series A round. This financing, led by 1315 Capital, a healthcare growth equity firm, will be used to drive continued growth as the company serves more consumers seeking to optimize their nutritional wellness and metabolic health.
”NutriSense is democratizing access to personalized health monitoring, which has long been elusive for individuals looking to take their health into their own hands,” said Alex Skryl, co-founder and CEO of NutriSense. “This financing is a testament to the strong and timely appetite for our product and ensures that we have the resources we need to continue bringing our tools and services to more members.”
The company will leverage this financing round to grow their operational team and to expand outreach to new members, taking strides in making health data and professional insight more accessible.
“We believe NutriSense offers a best-in-class solution that consumers engage with daily because it utilizes real-time glucose data paired with personalized dietitian insights that are actionable and trackable,” said Jessica Hou, Partner at 1315 Capital. “We have been impressed with the company’s business and subscription metrics as well as the impact the solution can make in a user’s metabolic health and quality of life.”
This growth financing continues the great momentum achieved since the company launched in 2019. To date, NutriSense has grown to over 120 teammates globally and has added thousands of subscription members to its user base.
For more information about NutriSense, visit https://www.nutrisense.io/.
About NutriSense
Founded in 2019, NutriSense is a metabolic health technology company with one simple mission: to help anyone discover and reach their health potential. Their unique approach of pairing data from continuous glucose monitoring technology with personalized 1-on-1 dietitian coaching is a key differentiator. The NutriSense platform allows members to personalize their nutrition, receive instant feedback to drive behavior change, and deliver an authentic human experience to guide members on their health journey.
To learn more about how NutriSense is democratizing access to health monitoring, visit: https://www.nutrisense.io/
About 1315 Capital
1315 Capital is a private investment firm with almost $900 million under management that provides expansion and growth capital to commercial-stage healthcare services, medical technology, therapeutics, and pharmaceutical services companies. 1315 Capital targets markets where high-quality management teams can rapidly scale platform companies into large and important businesses that positively impact patients, physicians, and the broader healthcare system. For more information, visit www.1315capital.com.
Contacts
Media:
Jess Bryant
SourceCode Communications
